Page 76 - Early Development News Today

The proposed changes are a big departure from how most other student representatives across the state are included in their local school boards.

A growing repertoire of cell and molecule-based immunotherapies is offering patients with indomitable cancers new hope by mobilizing their immune systems against tumor cells.

T cell bispecific antibodies (TCBs) are an emerging class of immunotherapeutics with several TCBs approved by the FDA for the treatment of leukemias, lymphomas, and myelomas. TCBs label tumor cells with one of their ends, and attract immune cells with another end to coerce them into tumor cell killing. However, one major challenge in the development of TCBs are “on-target, off-tumor” toxicities at sites in the body that also express TCB-targeted antigens. A new collaboration of Jennifer Lewi...

Norwich University Military Writers Symposium 2023 Schedule and Recorded Sessions including the Colby Award

Steps are underway to create new child care spaces in Hastings County. A new formal application process is get...

ZURZUVAE™ approved as first-and-only oral treatment specifically indicated for adults with postpartum depression and on-track for planned launch in the fourth quarter of 2023 shortly after DEA...

Joomla! - the dynamic portal engine and content management system

Alaska public school teachers short of supplies this year have a new source to turn to for funding, and it’s not the local school budget. Each teacher could receive $650

Summary. Medical Devices sector report, “Internal Fixators Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path...

Alaska’s Department of Education and Early Development will devote $2 million in federal pandemic relief money to fund school supplies.